IPM.ai Maps Referral Networks in a Rare Neurodegenerative Disease and Highlights Hotspots of Activity Across US
Client Challenge:
- Pre-commercial biotech looking to validate existing understanding of KOLs and identify potential new site investigators
- Company is pursuing a rare neurodegenerative disease, with complex symptomatology. Patients are commonly misdiagnosed, which adversely affects trial recruitment
- Client was also interested in understanding referral networks and the flow of patients to KOLs, high volume treaters and to its current trial investigators
IPM.ai Approach:
- Thoughtfully devised rules to identify the target patients in claims data
- Constructed a prioritized list of all diagnosing physicians, and mapped upstream referring HCPs through both explicit and implicit referral connections
- Provided mapped visualizations to depict geographic areas with high patient volume and HCP activity (along with corresponding data files)
Measurable Results:
- Delivered an immediately actionable list of referring providers, with statistics on patient flow to target providers for MSL outreach
- Successfully affiliated 84% of referring physicians to institutions, including specialty clinics and HCOs/IDNs
- Uncovered insights on upstream HCP specialties that played a critical role in both diagnosing and referring patients
- Mapped hotspots of patient concentration and discovered rural areas with significant patient population (due to genetic nature of the disease)
Sample Outputs:
Strength of Referral Network
Map of top HCPs (at ZIP level)
Target List and Referral Patterns
